Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Proshares Trust (ZBIO) Return on Equity (2024 - 2025)

Historic Return on Equity for Zenas BioPharma (ZBIO) over the last 2 years, with Q3 2025 value amounting to 0.89%.

  • Zenas BioPharma's Return on Equity rose 27700.0% to 0.89% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.89%, marking a year-over-year increase of 27700.0%. This contributed to the annual value of 3.72% for FY2024, which is N/A changed from last year.
  • Zenas BioPharma's Return on Equity amounted to 0.89% in Q3 2025, which was up 27700.0% from 0.69% recorded in Q2 2025.
  • Over the past 5 years, Zenas BioPharma's Return on Equity peaked at 0.2% during Q2 2024, and registered a low of 3.66% during Q3 2024.